Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone

Molecular and Cellular Biology

Volumn 25, Issue 17, 2005, Pages 7687-7695

  Ying, Hao ^a   Furuya, Fumihiko ^a   Willingham, Mark C ^b   Xu, Jianming ^c   O'Malley, Bert W ^c   Cheng, Sheue Yann ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; STEROID HORMONE RECEPTOR COACTIVATOR 3; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROTROPIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GROWTH REGULATION; GROWTH RETARDATION; HYPERCHOLESTEROLEMIA; HYPOPHYSIS THYROID SYSTEM; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE RESISTANCE;

BODY WEIGHT; CHOLESTEROL; DRUG RESISTANCE; HISTONE ACETYLTRANSFERASES; LIVER; ORGAN SIZE; RNA, MESSENGER; SIGNAL TRANSDUCTION; THYROID GLAND; THYROID HORMONE RECEPTORS BETA; THYROID HORMONES; TRANS-ACTIVATORS;

MAMMALIA;

EID: 23844482499     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.17.7687-7695.2005     Document Type: Article

References (26)

1. Beck-Peccoz, P., and V. K. Chatterjee. 1994. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4:225-232.
2. Cheng, S. Y. 2000. Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev. Endocrinol. Metab. Disord. 1:9-18.
3. Cheng, S. Y., S. Hasumura, M. C. Willingham, and I. Pastan. 1986. Purification and characterization of a membrane-associated 3,3′,5-triiodo- L-thyronine binding protein from a human carcinoma cell line. Proc. Natl. Acad. Sci. USA 83:947-951.
4. Crestani, M., W. G. Karam, and J. Y. Chiang. 1994. Effects of bile acids and steroid/thyroid hormones on the expression of cholesterol 7 alpha-hydroxylase mRNA and the CYP7 gene in HepG2 cells. Biochem. Biophys. Res. Commun. 198:546-553.
5. Furumoto, H., H. Ying, G. V. R. Chandramouli, L. Zhao, R. Walker, S. Meltzer, M. C. Willingham, and S. Cheng. 2005. An unliganded thyroid hormone receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol. Cell. Biol. 25:124-135.
6. Kamiya, Y., X. Y. Zhang, H. Ying, Y. Kato, M. C. Willingham, J. Xu, B. W. O'Malley, and S. Y. Cheng. 2003. Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone. Endocrinology 144:4144-4153.
7. Kaneshige, M., K. Kaneshige, X. Zhu, A. Dace, L. Garrett, T. A. Carter, R. Kazlauskaite, D. G. Pankratz, A. Wynshaw-Boris, S. Refetoff, B. Weintraub, M. C. Willingham, C. Barlow, and S. Cheng. 2000. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc. Natl. Acad. Sci. USA 97:13209-13214.
8. Leevers, S. J., D. Weinkove, L. K. MacDougall, E. Hafen, and M. D. Waterfield. 1996. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15:6584-6594.
9. McKenna, N. J., R. B. Lanz, and B. W. O'Malley. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocrinol. Rev. 20:321-344.
10. Pandak, W. M., D. M. Heuman, K. Redford, R. T. Stravitz, J. Y. Chiang, P. B. Hylemon, and Z. R. Vlahcevic. 1997. Hormonal regulation of cholesterol Reserved. 7 alpha-hydroxylase specific activity, mRNA levels, and transcriptional activity in vivo in the rat. J. Lipid Res. 38:2483-2491.
11. Parrilla, R., A. J. Mixson, J. A. McPherson, J. H. McClaskey, and B. D. Weintraub. 1991. Characterization of seven novel mutations of the c-erbA betagene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J. Clin. Investig. 88:2123-2130.
12. Patel, S., P. A. Lochhead, G. Rena, S. Fumagalli, M. Pende, S. C. Kozma, G. Thomas, and C. Sutherland. 2002. Insulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activity. J. Biol. Chem. 277:9889-9895.
13. Refetoff, S., R. E. Weiss, and S. J. Usala. 1993. The syndromes of resistance to thyroid hormone. Endocrinol. Rev. 14:348-399.
14. Smith, C. L., and B. W. O'Malley. 2004. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocrinol. Rev. 25:45-71.
15. Suzuki, H., and S. Y. Cheng. 2003. Compensatory role of thyroid hormone receptor (TR) α1 in resistance to thyroid hormone: study in mice with a targeted mutation in the TR β gene and deficient in TRα1. Mol. Endocrinol. 17:1647-1655.
16. Suzuki, H., X. Y. Zhang, D. Forrest, M. C. Willingham, and S. Y. Cheng. 2003. Marked potentiation of the dominant-negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele. Mol. Endocrinol. 17:895-907.
17. Torres-Arzayus, M. I., J. F. De Mora, J. Yuan, F. Vazquez, R. Bronson, M. Rue, W. R. Sellers, and M. Brown. 2004. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6:263-274.
18. Wang, Z., D. W. Rose, O. Hermanson, F. Liu, T. Herman, W. Wu, D. Szeto, A. Gleiberman, A. Krones, K. Pratt, R. Rosenfeld, C. K. Glass, and M. G. Rosenfeld. 2000. Regulation of somatic growth by the p160 coactivator p/CIP. Proc. Natl. Acad. Sci. USA 97:13549-13554.
19. Weiss, R. E., and S. Refetoff. 2000. Resistance to thyroid hormone. Rev. Endocrinol. Metab. Disord. 1:97-108.
20. Williams, G. R. 2000. Cloning and characterization of two novel thyroid hormone receptor beta isoforms. Mol. Cell. Biol. 20:8329-8342.
21. Xu, J., L. Liao, G. Ning, H. Yoshida-Komiya, C. Deng, and B. W. O'Malley. 2000. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. USA 97:6379-6384.
22. Xu, J., Y. Qiu, F. J. DeMayo, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1998. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922-1925.
23. Yen, P. M. 2001. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81:1097-1102.
24. Yen, P. M. 2003. Molecular basis of resistance to thyroid hormone. Trends Endocrinol. Metab. 14:327-333.
25. Ying, H., H. Suzuki, H. Furumoto, R. Walker, P. Meltzer, M. C. Willingham, and S. Y. Cheng. 2003. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma. Carcinogenesis 24:1467-1479.
26. Zhou, G., Y. Hashimoto, I. Kwak, S. Y. Tsai, and M. J. Tsai. 2003. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol. Cell. Biol. 23: 7742-7755.